See also this year's filing and all EDGAR filings for this company.
PDF Report 0001784440_2025_Bioscience_Health_Innovations_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'Bollinger Innovations INC', 'shared_tokens': {'innovations'}}]} |
| warning | Missing logo | subcommand.report | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.08003593245474494, 'aggregate_val': 1707181, 'exp_sum': 1855704, 'exp_to_value': {'AssetsCurrent': 1558658, 'AssetsNonCurrent': 148523, 'IntangibleAssets': 82887, 'remainder_Assets': 65636}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001784440, Bioscience Health Innovations Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 847,751 |
| 1 | AssetsNonCurrent | 0 |
| 2 | IntangibleAssets | 26,037 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 0 |
| 5 | LiabilitiesNonCurrent | 0 |
| 6 | remainder_Liabilities | 38,548 |
| 7 | CostOfGoodsAndServicesSold | 536,078 |
| 8 | SellingExpense | 1,146,410 |
| 9 | GeneralAndAdministrativeExpense | 0 |
| 10 | ResearchAndDevelopment | 0 |
| 11 | DepreciationDepletionAndAmortization | 0 |
| 12 | remainder_Expenses | 75,478 |
| 13 | remainder_Revenues | 1,844,966 |
| 14 | remainder_NetIncome | 0 |
| 15 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 873,788 |
| 1 | Liabilities | 38,548 |
| 2 | Expenses | 1,757,966 |
| 3 | Revenues | 1,844,966 |
| 4 | StockholdersEquity | 835,240 |
| 5 | NetIncome | 87,000 |
| 6 | ComprehensiveNetIncome | 87,000 |
| 7 | BaseVar | 3,158,367 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.05 |
| 9 | EconomicCapitalRatio | 3.90 |
Edgar->Model Mapping
Feature Distribution
Change over Time
